CDC and ATSDR Health Message Testing System

OMB Control No: 0920-0572	ICR Reference No: 201502-0920-001
Status: Historical Active	Previous ICR Reference No: 201501-0920-003
Agency/Subagency: HHS/CDC	Agency Tracking No:
Title: CDC and ATSDR Health Message Testing System
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 03/30/2015
Retrieve Notice of Action (NOA)	Date Received in OIRA: 02/11/2015
Terms of Clearance: Approved consistent with the following terms of clearance: For each information collection, a GenIC information collection request will be prepared and submitted to OMB for review and approval. Any changes to the ICR will also be submitted to OMB for review and approval.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	03/31/2018	36 Months From Approved	03/31/2015
Responses	55,575	0	55,575
Time Burden (Hours)	7,410	0	7,510
Cost Burden (Dollars)	0	0	0

---

Abstract: CDC must communicate about hazards, outbreaks and other emergencies that present an urgent health threat to the public. Untested messages can waste communication resources and opportunities because the messages can be perceived as unclear or irrelevant. OADC-CDC requests an extension for the generic clearance for an expedited review of items to be used in health message testing to ensure the public will understand health messages and take recommended action.

---

Authorizing Statute(s): US Code: 42 USC 241 Name of Law: Public Health Service Act

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	79 FR 69478	11/21/2014
30-day Notice:	Federal Register Citation:	Citation Date:
	80 FR 7477	02/10/2015
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 34

IC Title Form No. Form Name HMTS - Formative evaluation of Zika prevention strategies and messages among pregnant women and community leaders in Puerto Rico NA, NA, NA, NA, NA, NA Focus Group Discussion with Community Leaders in Puerto Rico to Explore Possible Actions for Preventing Zika ,   Focus Group Discussion with Pregnant Women in Puerto Rico to Explore Possible Actions for Preventing Zika ,   Focus Group Discussion with Pregnant Women in Puerto Rico To Test Zika Prevention Messages ,   In-depth Interview of Community Leaders in Puerto Rico to Explore Possible Actions for Preventing Zika ,   In-depth Interview of Pregnant Women in Puerto Rico to Explore Possible Actions for Preventing Zika ,   In-depth Interview of Pregnant Women in Puerto Rico To Test Zika Prevention Messages High Impact Prevention Message Testing (HIPMT) NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA Consumer Focus Group Guide ,   Consumer IDI Guide ,   Provider Focus Group Guide ,   Provider IDI Guide ,   Professional Focus Group Guide ,   Professional IDI Guide ,   Consumer - Brief Survey ,   Provider - Brief Survey ,   Professional - Brief Survey ,   Consumer - Screener ,   Provider - Screener ,   Professional - Screener ,   Consumer - Consent ,   Provider - Consent ,   Professional - Consent ,   Consumer Web Survey ,   Intercept Guide ,   Screener - Consumer Web Survey ,   Consent - Consumer Web Survey ,   Consent - Intercept Survey Asthma Control Initiative Communication Messaging and Materials Development none Focus Group Screener GenIC Testing of Spanish-language Messages for the National Diabetes Domestic Readiness Initiative on Zika Virus Disease 0920-0572, 0920-0572, 0920-0572, 0920-0572, 0920-0572, 0920-0572 Attachment 4 - Provider Screener_1_13 ,   Attachment 5 - Provider Survey_1_13 ,   Attatchment 6 - FGPRScreener_1_13 ,   Attachment 7 - FGPRGuide_1-13-17 ,   ttachment2 - Consumer Screener for IDICONUS_1_13 ,   Attachment 3 consumer IDI Guide_l1_13 Interim Assessment of Messages for the Prescription Drug Overdose Prevention, Awareness, and Knowledge Building Campaign N/A Screen Shots of the Prescription Drug Overdose Survey Bring Your Brave Campaign Message Testing none Bring Your Brave Campaign Testing Survey HEADS UP Audience Research Study NA, NA FOCUS GROUP SCREENER AND FOLLOW UP FOCUS GROUP SCREENER ,   FOCUS GROUP AND FOLLOW UP FOCUS GROUP INSTRUMENT Air Quality Information Initiative none Recruitment screener Domestic Readiness Initiative on Zika Virus Disease - Year 2 Core Campaign Materials NA, NA Focus Group Screener ,   Focus Group Guide Focus Group Research to Inform the Development of Mesages to change Social Norms Att. F2, Att. F1 Att. F1 Dads book ,   Att. F2 Moms book Message testing among partners of pregnant women in Puerto Rico NA, NA Intercept Interviews with Public Audiences in Puerto Rico to test Zika Prevention Messages - English ,   Intercept Interviews with Public Audiences in Puerto Rico to test Zika Prevention Messages - Spanish Re-entry Messaging Following a Radiation Emergency Older Adult Mobility Planning Brochure none Participant Screener Domestic Readiness Initiative on Zika Virus Disease: Year 2 Message & Materials Testing NA, NA, NA, NA Community Leader - Focus Group Screening Instrument ,   Men/Women Reproductive Age (18-49) - Focus Group Screening Instrument ,   Community Leader - Focus Group Guide ,   Men/Women Reproductive Age (18-49) - Focus Group Guide CDC/NCEH TO21: Outdoor Air Quality Focus Group "Bring Your Brave" Campaign Messages for Young Women and Health Care Providers 0920-0572, 0920-0572, 0920-0572, 0920-0572 Screening Instrument for Young Women ,   Survey Instrument for Young Women ,   Screening Instrument for Health Care Providers ,   Survey Instrument for Health Care Providers Sepsis Educational Awareness Message/Materials Assessment - HCP none Sepsis Educational Awareness Assessment Sepsis Campaign Development: Round 2 Concept/Materials Testing for Healthcare Providers n/a Screenshots of the Sepsis Survey for Healthcare Professionals HMTS - Message testing among important public audiences in Puerto Rico NA Intercept Interviews with Public Audiences in Puerto Rico to test Zika Prevention Messages Intercept Interviews with Travelers in Puerto Rico To Test Zika Prevention Messages NA, NA Intercept Interviews with Public Audiences in Puerto Rico To Test Zika Prevention Messages - English ,   Intercept Interviews with Public Audiences in Puerto Rico To Test Zika Prevention Messages - Spanish Sepsis Educational Awareness Message/Materials Assessment - Consumers none Sepsis Assessment - Consumers Radiation Concepts/Comparison Message Testing none, none Interview Screener ,   Focus Group Screener Office of the Associate Director for Communication (OADC) Message and Material Feedback NA, NA OADC Message and Material Feedback Survey - Screener ,   OADC Message and Material Feedback Survey - Health Material Questions Message Testing with Mothers for CDC's Division of Nutrition, Physical Activity, and Obesity (DNPAO) n/a, n/a Screener and Survey for Online Participants (content is provided in screen shots and Word) ,   Screener and Moderator's Guide for In-person Focus Group Participants Assess Perception and Use of CDC Guideline for Prescribing Opioids for Chronic Pain none CDC Prescription Opioid Physician Survey Skin Cancer Messages among Racial Ethnic Groups at Risk for Delayed Diagnosis, Advanced Disease and Lower Survival N/A, N/A, N/A, N/A, N/A, N/A, N/A Screener ,   Informed Consent and Rescreening Form ,   Focus Group Discussion Guide for African American Women ,   Focus Group Discussion Guide for Hispanic Women ,   Focus Group Discussion Guide for African American Men ,   Focus Group Discussion Guide for Hispanic Men ,   Digital Ad Response Sheet (completed during focus groups with men) Antibiotic Use Campaign: Round 2 (R2) Concept/Materials Testing with Consumers n/a, n/a, n/a, n/a, n/a Pre-discussion Information Survey for Consumers (Self-demanders and Self-expectors) ,   Pre-discussion Information Survey for Consumers (Caregiver-demanders and Caregiver-expectors) ,   Online Focus Group Guide for Consumers ,   Screener for Consumers (Self-demanders and Self-expectors) ,   Screener for Consumers (Caregiver-demanders and Caregiver-expectors) Antibiotic Use Campaign: Round 2 (R2) Concept/Materials Testing with Health Care Professionals n/a, n/a, n/a Screener for Health Care Professionals ,   Pre-Discussion Information Survey for Health Care Professionals ,   In-Depth Interview Guide for Health Care Professionals Message Testing among Public Audiences in US Virgin Islands for Zika prevention none Intercept interview for message testing Asthma Control Communication Materials Field Testing (NCEH) none, none, none, none, none Foduc Group Screener ,   Youth Rating Worksheet ,   Caregiver Rating Worksheet ,   Youth Comparison Worksheet ,   Caregiver Comparison Worksheet Be Antibiotics Aware Educational Message/Materials Assessment n/a Be Antibiotics Aware Consumer Survey (BAACS) Sepsis Campaign Development: Round 2 Concept/Materials Testing for Consumers n/a Screenshots of the Sepsis R2 Survey for Consumers American Academy of Pediatrics Oral Health Toolkit Research and Message Testing

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	55,575	55,575	0	0	0	0
Annual Time Burden (Hours)	7,410	7,510	0	-100	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Miscellaneous Actions

Short Statement: Burden change reverts estimated numbers back to original ICR; additional hours were added previously due to an unusually burdensome genIC.

---

Annual Cost to Federal Government: $1,550,000

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

Agency Contact: Shari Steinberg 404 639-4942 [email protected]

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
		(a) It is necessary for the proper performance of agency functions;
		(b) It avoids unnecessary duplication;
		(c) It reduces burden on small entities;
		(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
		(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
		(f) It indicates the retention periods for recordkeeping requirements;
		(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
			(i) Why the information is being collected;
			(ii) Use of information;
			(iii) Burden estimate;
			(iv) Nature of response (voluntary, required for a benefit, or mandatory);
			(v) Nature and extent of confidentiality; and
			(vi) Need to display currently valid OMB control number;
		(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
		(i) It uses effective and efficient statistical survey methodology (if applicable); and
		(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date: 02/11/2015

---